Therefore, we took advantage of mice expressing the Cre recombinase under the control of the Runx2 promoter [5] with the aim to delete p53 selectively in osteoblast progenitor cells to enable osteosarcoma development. The gene discussed is RUNX2; the disease is osteosarcoma.